Clinical Oncology
The Academic Board of the Royal Society of Medicine selected clinical oncology as the subject for the Society's first postgraduate study course and this was held during the week Monday 13 to Friday 17 September 1976. The programme was designed for clinicians with a particular interest in oncology and was attended by lecturers, registrars and consultants, from both the United Kingdom and overseas.
The Section of Oncology, formed in 1970, was the first new Section of the Society to be founded for many years, and was an expression of the growing feeling that oncology should be more coordinated than hitherto. Now that there is a real likelihood that the subject will become recognized as a specialty, we may expect proper career structures to develop which will ensure that Britain is provided in the future with experienced consultant oncologists. The course at the RSM was an example of how many of the varied areas within clinical oncology might be brought together, thus achieving a multidisciplinary atmosphere which is so essential for the management of malignant disease.
Of the 130 delegates who attended, nearly half came from overseas. Nine major areas of the subject were covered in the symposia, these being interspersed with five guest lectures in special topics. This coverage, although comprehensive, was inevitably far from complete. However, it has been proposed that a similar course should be held in 1977, and possibly the event will become an annual one in the Society's calendar. If this happens, then there will be the opportunity of covering all aspects of clinical oncology eventually, as well as including contributions on clinical and experimental cancer research which have a particular relevance to the topics being considered.
The first session of the course, on the Epidemiology of Cancer, emphasized this last point. It included two review talks, on geographical pathology and on industrial carcinogenesis, and other contributions which dealt more specifically with air pollution and smoking and the use of female sex hormones and the contraceptive pill in relation to the induction of human cancers. This topic was followed by sessions on Diagnostic Methods, with especial emphasis on the use of the EMI body scanner, recent advances in endoscopic techniques and isotopic methods, and papers which reviewed the role of cytodiagnosis and immunodiagnosis.
The second day began with the first of the guest lectures, in which Mr Ian Burn emphasized the great importance of using the TNM system of classification in the assessment of the efficacy of treatment and in unifying the interpretation of comparative studies. He stressed that it was particularly important to use a standard classification to define the extent of the disease when combined methods of treatment were being evaluated. This lecture was followed by a session on Chemotherapy and Immunotherapy, in which there were contributions both of a general and of a specific kind which reviewed the recent advances made in the medical treatment of cancer. The contribution on the potential of immunotherapy stressed the fact that no substantial evidence exists as yet to justify the use of immunotherapeutic techniques in clinical practice, but indicated that research must be continued in this field in the hope that it will provide a means of controlling minimal disease which might remain after the application of surgery, radiotherapy, and chemotherapy. This session was followed by a lively period ofdiscussion in which many of the delegates made valuable contributions from their own experience.
The subject of the symposium held on the second afternoon was The Reticuloses; it dealt with management of the leukemias in children and adults, and of Hodgkin's disease and the nonHodgkin lymphomas. Much of the discussion centred upon the dilemma of pursuing treatment schedules for the help of patients with myeloblastic leukvmia, knowing that this form of leukemia Clinical Oncology does not share with lymphoblastic leukemia the favourable characteristics which have made for striking successes in the latter. It was pointed out that the same problem of offering distressing, and at times dangerous treatment with cytotoxic drugs had presented earlier workers with serious moral misgivings in their attempts to treat patients with acute lymphoblastic leukaemia. However, time and experience had shown that these active treatments had in fact been vindicated by the successes achieved.
In the case of myeloblastic leukumia a similar problem now exists, but with the knowledge gained during the past few years, which has shown that the drugs currently available are less selectively toxic to myeloblastic leukemic cells than to lymphoblastic ones, that the kinetics of recovery of normal bone marrow cells are less advantageous and that the myeloblastic cells are more prone to develop drug resistance, difficult questions have been raised in assessing the wisdom of applying such treatment schedules until new cytotoxic agents are available.
In contrast to this problem, encouraging results were reported about advances in the treatment and management of lymphoblastic leukemia and Hodgkin's disease, with particular emphasis on the ways in which the families of patients can be helped.
The third day of the course started with a challenging lecture by Professor R A Sellwood on the questions of screening for early cancers, with especial emphasis on cancer of the breast. Professor Sellwood gave a very clear and emphatic account of the case for promoting the screening of women in the age group which is most at risk, provided that this could be done by medical or ancillary personnel who were very experienced and who had access to the latest techniques in which the radiation dose can be minimized to levels which are safe for repeated examinations. His lecture set the scene for an exceptionally interesting session on Cancer of the Breast in which the separate and combined roles of surgery, radiotherapy and chemotherapy were argued. The session also included a contribution on the biochemical work that had been undertaken in an attempt to define women who are especially at risk in terms of the patterns of their steroid excretion. It had to be acknowledged that no adequate biochemical discriminant function had yet been found which would make it possible to give a satisfactorily limited definition of the population particularly at risk. But the possibility that a multi-parametric biochemical criterion could be established made it important for research to be continued in this field, since it seemed clear that limitations of money and skilled manpower would only make mammography feasible if a simple means could be found to identify the women most likely to develop the disease. This session was followed by a most interesting discussion period in which the speakers participated with the audience, as a panel, raising and answering many important questions.
In the afternoon session on Gynaecological Cancer, the limitation of time made it possible for only three aspects of the subject to be dealt with, and it was clear that this field should be given much greater emphasis in future programmes. The day concluded with a guest lecture by Mr R W Raven, who gave a very stimulating review of the particularly difficult problems presented by the management and treatment of solid tumours in children. He emphasized the importance of early diagnosis and reviewed many of the techniques now available, stressing the great importance of making comprehensive investigations before deciding whether active treatment aimed at a cure, or palliative treatment should be undertaken. He gave many examples of the successful treatment, by combined regimes, of cases which might have been judged untreatable only a few years ago.
The fourth day of the course was introduced by a lecture on Gastrointestinal Cancer by Dr B Morson, who gave a comprehensive review of the pathological characteristics of malignancy in all its forms in the gastrointestinal tract. He related the different pathological pictures encountered to the methods of treatment most appropriate to each form of the disease and made especial reference to the importance of early diagnosis, noting particularly the advances that have been made in recent years in Japan in the early diagnosis of gastric cancer. His lecture was followed by four contributions on different aspects of treatment, management and research related to cancer of the stomach, the small bowel, the large bowel, and of the liver, pancreas and periampullary region.
On the final day, Professor D F N Harrison delivered a forceful lecture on the treatment and management of tumours of the head and neck, in which he demonstrated that, notwithstanding the rather poor long-term results of treatment, it was now possible to undertake extensive facial operations with a palliative intent. 
